You Know It’s a Placebo. So Why Does It Still Work?
As researchers try to make sense of “open-label” placebos—fake drugs that proudly announce their fakeness—the mysterious effect is starting to show ..
As researchers try to make sense of “open-label” placebos—fake drugs that proudly announce their fakeness—the mysterious effect is starting to show ..
Eli Lilly is about to release Zepbound, a new entrant in the superheated competition for blockbuster weight loss drugs. ..
An unprecedented look at dopamine in the brain reveals that psychosis drugs get developed with the wrong neurons in mind. ..
Current treatments for depression after giving birth are either slow to work or hard to get. The FDA is considering a new tablet that relieves symptoms ..
Five people went into viral remission after stem cell transplants from donors with HIV resistance. A sixth patient received normal cells. Is an anti-inflammatory ..
Two long-awaited fungus killers are about to roll out. But if one is widely deployed first, it might breed resistance and make the other useless. ..
A key tool in the early pandemic response, monoclonal antibodies are now ineffective against new variants. Immunocompromised patients are especially at risk. ..
These tiny organoids with working immune systems mimic the function of the GI tract and could be used to study intestinal diseases and drugs to treat them. ..
Researchers have created autonomous particles covered with patches of protein “motors.” They hope these bots will tote lifesaving drugs through bodily ..
Growing organoids in dishes and xenografts in mice lets scientists re-create a living person’s tumor—and test dozens of drugs against them at the same ..